Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liovel Combination Tablets Long-term Use Surveillance in Type 2 Diabetes Mellitus
jRCT1080222253
- Sponsor
- Takeda
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of alogliptin + pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda.
02
Drugs
alogliptin + pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080222253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222253.